Clearbridge Investments LLC cut its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,151,851 shares of the technology company's stock after selling 81,213 shares during the quarter. Clearbridge Investments LLC owned 0.12% of Relx worth $97,737,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of RELX. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company's stock worth $89,420,000 after acquiring an additional 658,655 shares during the last quarter. Brown Brothers Harriman & Co. lifted its stake in Relx by 218.5% during the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after purchasing an additional 662 shares during the last quarter. Zions Bancorporation N.A. boosted its holdings in shares of Relx by 69.0% in the 4th quarter. Zions Bancorporation N.A. now owns 69,710 shares of the technology company's stock worth $3,166,000 after purchasing an additional 28,454 shares in the last quarter. Congress Wealth Management LLC DE increased its position in shares of Relx by 8.7% during the 4th quarter. Congress Wealth Management LLC DE now owns 9,630 shares of the technology company's stock valued at $437,000 after purchasing an additional 772 shares during the last quarter. Finally, LPL Financial LLC raised its holdings in shares of Relx by 20.9% during the 4th quarter. LPL Financial LLC now owns 230,589 shares of the technology company's stock valued at $10,473,000 after buying an additional 39,882 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company's stock.
Analysts Set New Price Targets
Several analysts have issued reports on RELX shares. Redburn Atlantic started coverage on Relx in a research note on Wednesday, January 8th. They issued a "buy" rating for the company. The Goldman Sachs Group began coverage on shares of Relx in a research note on Wednesday, March 26th. They issued a "buy" rating for the company. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Finally, Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy".
Check Out Our Latest Analysis on Relx
Relx Trading Down 6.3 %
Relx stock traded down $3.23 during trading hours on Friday, reaching $48.21. The company had a trading volume of 1,321,661 shares, compared to its average volume of 722,723. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a 12-month low of $40.25 and a 12-month high of $51.99. The company has a 50-day moving average price of $49.62 and a 200 day moving average price of $47.91. The firm has a market cap of $89.48 billion, a price-to-earnings ratio of 25.92, a P/E/G ratio of 2.73 and a beta of 0.84.
Relx Increases Dividend
The company also recently announced a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be paid a $0.5586 dividend. This represents a dividend yield of 1.6%. This is an increase from Relx's previous semi-annual dividend of $0.23. The ex-dividend date is Friday, May 9th. Relx's payout ratio is presently 59.68%.
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
